ZEAL.CO
Zealand Pharma A/S
CopenhagenDKKEQUITY
DELAYED
Last price
321.20
▲ 6.60 (2.10%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
320.20
Prev close
314.60
Day high
326.30
Day low
311.50
Volume
463.17K
Market cap
—
P/E (TTM)
—
52W range
233.50 – 556.00
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
+8.18%
+4.5%
3M
+1.01%
-2.1%
6M
-17.66%
-28.7%
YTD
-31.13%
-43.4%
1Y
-13.40%
-33.4%
3Y
+30.68%
-43.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on ZEAL.CO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $9.21B | $62.69M | $342.79M | $103.99M | +14,598.9% |
| Operating revenue | $9.21B | $62.69M | $342.79M | $103.99M | +14,598.9% |
| Cost of revenue | $816.00K | $7.87M | $19.17M | $0 | -89.6% |
| Gross profit | $9.21B | $54.82M | $323.61M | $103.99M | +16,708.7% |
| Research & development | $1.60B | $919.87M | $684.90M | $614.04M | +74.4% |
| Selling, general & admin | $273.09M | $229.20M | $89.85M | $306.54M | +19.1% |
| Total operating expense | $2.10B | $1.32B | $900.83M | $920.59M | +58.7% |
| Operating income | $7.11B | -$1.27B | -$577.22M | -$816.60M | +660.5% |
| Net interest income | $271.64M | $128.74M | $16.34M | -$48.68M | +111.0% |
| Pre-tax income | $7.00B | -$1.08B | -$708.87M | -$972.04M | +746.2% |
| Tax provision | $546.06M | -$4.62M | -$5.13M | -$6.43M | +11,927.1% |
| Net income | $6.46B | -$1.08B | -$703.74M | -$1.20B | +698.3% |
| Net income to common | $6.46B | -$1.08B | -$703.74M | -$1.20B | +698.3% |
| Basic EPS | 91.56 | -16.24 | -12.44 | -26.02 | +663.8% |
| Diluted EPS | 90.22 | -16.24 | -12.44 | -26.02 | +655.5% |
| EBIT | $7.03B | -$1.05B | -$683.03M | -$915.59M | +769.9% |
| EBITDA | $7.06B | -$1.02B | -$657.95M | -$797.63M | +789.5% |
| Basic shares | 70.50M | 66.43M | 56.59M | 46.20M | +6.1% |
| Diluted shares | 71.55M | 66.43M | 56.59M | 46.20M | +7.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.58B | $726.03M | $449.31M | $1.07B | +530.3% |
| Cash & short-term investments | $15.11B | $8.23B | $1.63B | $1.18B | +83.7% |
| Accounts receivable | $336.00K | $499.00K | $97.80M | $115.62M | -32.7% |
| Inventory | $0 | $10.70M | $7.93M | $1.29M | -100.0% |
| Total current assets | $15.67B | $8.53B | $1.78B | $1.32B | +83.8% |
| Property, plant & equipment | $151.43M | $125.25M | $149.85M | $165.49M | +20.9% |
| Goodwill & intangibles | $44.97M | $12.62M | $12.26M | $0 | +256.3% |
| Total assets | $15.95B | $9.51B | $1.98B | $1.54B | +67.8% |
| Total current liabilities | $664.97M | $403.47M | $284.58M | $195.49M | +64.8% |
| Long-term debt | $302.92M | $285.33M | $0 | $320.74M | +6.2% |
| Total debt | $405.77M | $391.76M | $119.23M | $443.47M | +3.6% |
| Total liabilities | $1.12B | $888.86M | $387.15M | $723.89M | +25.8% |
| Retained earnings | $6.29M | -$6.16B | -$4.89B | -$4.17B | +100.1% |
| Shareholder equity | $14.83B | $8.62B | $1.59B | $815.91M | +72.1% |
| Working capital | $15.01B | $8.12B | $1.50B | $1.12B | +84.7% |
| Net tangible assets | $14.79B | $8.60B | $1.58B | $815.91M | +71.8% |
| Shares issued | 71.52M | 71.02M | 58.75M | 51.70M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $6.46B | -$1.08B | -$703.74M | -$1.20B | +698.3% |
| Depreciation & amortisation | $27.37M | $25.85M | $25.09M | $117.96M | +5.9% |
| Stock-based compensation | $115.89M | $87.03M | $61.43M | $52.29M | +33.2% |
| Change in working capital | $87.73M | $117.76M | $52.10M | $10.16M | -25.5% |
| Operating cash flow | $6.53B | -$930.82M | -$425.67M | -$942.31M | +801.7% |
| Capital expenditure | -$69.07M | -$13.15M | -$23.75M | -$11.71M | -425.3% |
| Investing cash flow | -$2.25B | -$7.31B | -$1.09B | $281.26M | +69.2% |
| Share buybacks | -$407.17M | -$351.83M | -$41.60M | $0 | -15.7% |
| Financing cash flow | -$378.18M | $8.29B | $907.01M | $587.50M | -104.6% |
| Free cash flow | $6.46B | -$943.96M | -$449.42M | -$954.02M | +784.7% |
| End cash position | $4.58B | $726.03M | $449.31M | $1.07B | +530.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $34.00M | $68.92M | $49.57M | $9.09B | $8.00M | -50.7% |
| Operating revenue | $34.00M | $68.92M | $49.57M | $9.09B | $8.00M | -50.7% |
| Cost of revenue | $0 | $0 | $0 | $410.00K | $0 | — |
| Gross profit | $34.00M | $68.92M | $49.57M | $9.09B | $8.00M | -50.7% |
| Research & development | $469.00M | $530.07M | $320.04M | $464.14M | $290.00M | -11.5% |
| Selling, general & admin | $104.00M | -$131.05M | $190.85M | $110.46M | $102.00M | +179.4% |
| Total operating expense | $573.00M | $425.46M | $510.89M | $749.45M | $392.00M | +34.7% |
| Operating income | -$539.00M | -$356.54M | -$461.32M | $8.34B | -$384.00M | -51.2% |
| Net interest income | $66.00M | $89.24M | $101.55M | $47.29M | $32.00M | -26.0% |
| Pre-tax income | -$394.00M | -$406.51M | -$366.73M | $8.11B | -$336.00M | +3.1% |
| Tax provision | $0 | -$27.39M | $37.50M | $537.32M | -$1.00M | +100.0% |
| Net income | -$394.00M | -$379.12M | -$404.23M | $7.57B | -$335.00M | -3.9% |
| Net income to common | -$394.00M | -$379.12M | -$404.23M | $7.57B | -$335.00M | -3.9% |
| Basic EPS | -5.58 | — | -5.75 | 107.08 | -4.74 | — |
| Diluted EPS | -5.58 | — | -5.75 | 105.61 | -4.74 | — |
| EBIT | -$389.00M | -$399.44M | -$359.74M | $8.12B | -$328.00M | +2.6% |
| EBITDA | -$379.00M | -$391.46M | -$352.51M | $8.13B | -$323.00M | +3.2% |
| Basic shares | 70.61M | — | 70.30M | 70.73M | 70.68M | — |
| Diluted shares | 70.61M | — | 70.30M | 71.71M | 70.68M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.85B | $4.58B | $5.97B | $7.24B | $776.15M | — | -15.9% |
| Cash & short-term investments | $14.47B | $15.11B | $16.17B | $16.58B | $8.54B | — | -4.2% |
| Accounts receivable | $5.00M | $336.00K | $6.78M | $2.17M | $8.08M | — | +1,388.1% |
| Inventory | — | $0 | $0 | $10.30M | $10.70M | $10.70M | — |
| Total current assets | $15.02B | $15.67B | $16.62B | $17.01B | $8.96B | — | -4.2% |
| Property, plant & equipment | $164.00M | $151.43M | $141.39M | $134.16M | $129.62M | — | +8.3% |
| Goodwill & intangibles | $45.00M | $44.97M | $12.73M | $13.59M | $14.14M | — | +0.1% |
| Total assets | $15.30B | $15.95B | $16.80B | $17.18B | $9.12B | — | -4.1% |
| Total current liabilities | $404.00M | $664.97M | $1.18B | $1.13B | $356.85M | — | -39.2% |
| Long-term debt | $307.00M | $302.92M | $298.45M | $294.00M | $289.78M | — | +1.3% |
| Total debt | $414.00M | $405.77M | $406.44M | $396.95M | $394.64M | — | +2.0% |
| Total liabilities | $832.00M | $1.12B | $1.63B | $1.57B | $813.74M | — | -25.6% |
| Retained earnings | -$356.00M | $6.29M | $355.04M | $803.23M | -$6.47B | — | -5,762.5% |
| Shareholder equity | $14.47B | $14.83B | $15.16B | $15.61B | $8.31B | — | -2.4% |
| Working capital | $14.61B | $15.01B | $15.44B | $15.89B | $8.60B | — | -2.6% |
| Net tangible assets | $14.42B | $14.79B | $15.15B | $15.60B | $8.29B | — | -2.4% |
| Shares issued | 71.53M | 71.52M | 71.36M | 71.34M | 71.05M | — | +0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$394.00M | -$379.12M | -$404.23M | $7.57B | -$335.00M | — | -3.9% |
| Depreciation & amortisation | $10.00M | $7.98M | $7.22M | $7.17M | $5.00M | — | +25.3% |
| Stock-based compensation | $32.00M | $30.36M | $30.81M | $31.72M | $23.00M | — | +5.4% |
| Change in working capital | -$280.00M | $525.15M | -$164.60M | -$91.83M | -$181.00M | — | -153.3% |
| Operating cash flow | -$672.00M | -$1.04B | -$443.77M | $8.52B | -$501.00M | — | +35.6% |
| Capital expenditure | -$11.00M | -$49.94M | -$3.64M | -$7.49M | -$8.00M | — | +78.0% |
| Investing cash flow | -$116.00M | -$373.44M | -$855.43M | -$1.57B | $555.00M | — | +68.9% |
| Share buybacks | — | $1.00K | -$74.76M | — | — | $0 | — |
| Financing cash flow | -$8.00M | $10.64M | -$78.28M | -$309.54M | -$1.00M | — | -175.2% |
| Free cash flow | -$683.00M | -$1.09B | -$447.42M | $8.51B | -$509.00M | — | +37.5% |
| End cash position | $3.85B | $4.58B | $5.97B | $7.24B | $776.00M | — | -15.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
323.61
-0.74% from price
SMA 20
318.25
+0.93% from price
SMA 50
301.84
+6.41% from price
SMA 100
303.97
+5.67% from price
SMA 200
364.58
-11.90% from price
EMA 12
319.70
+0.47% from price
EMA 26
314.46
+2.14% from price
EMA 50
309.87
+3.66% from price
RSI (14)
54.1
Neutral
MACD (12,26,9)
5.24
Hist -1.50
ATR (14)
14.37
4.47% of price
Realised vol 30D
36.9%
Annualised
Bollinger upper
341.16
20, 2σ
Bollinger lower
295.34
20, 2σ
50 / 200 cross
Death
301.84 vs 364.58
Trend bias
Below 200
-11.90%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.20
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
36.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-57.0%
Peak to trough
Max drawdown 5Y
-75.4%
Peak to trough
ATR 14
14.37
4.47% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Does Main Street Capital's Dividend Still Come Out of Earnings, or Out of the Balance Sheet?
Motley Fool · 15m ago
Macy's has a $250 9-piece comforter set for 70% off that's 'nice and fluffy'
TheStreet · 20m ago
South Korean survivor fights for workplace harassment 'justice'
AFP · 27m ago
Messi scores but Miami slump continues with loss to Toronto
AFP · 28m ago
Can't-Miss Play: It's DeGennaro! Behren Morton lofts up beauty to Nick DeGennaro for 37-yard TD
NFL Highlights · 33m ago
Josh Johnson's best plays from 2-TD game vs. Bears Preseason Week 2
NFL Highlights · 33m ago
Sydney marathon unveils medal with wrong stadium
AFP · 38m ago
Prince Harry: royal misfit making unlikely UK return
AFP · 40m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.